[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Canada Update", "description": "Great Canadian update from Lindsay, thank you. \nFriendly Pharmacy 5: https://www.youtube.com/c/FriendlyPharmacy5\nVideos:\n\u2022 Vitamin D & Immunity: https://youtu.be/0dIAyLLhUFg\n\u2022 Oxford/AstraZeneca Vaccine: https://youtu.be/JNR79zDAyj0\n\u2022 COVID-19 VACCINE Q&A PART 1: Ingredients, Speed of Production, mRNA: https://youtu.be/l_LpsPKrxs0\n\n\u2022 Interval between vaccine doses stretched up to 4 months: https://www.cbc.ca/news/politics/naci-interval-advice-change-four-months-1.5934563\n\u2022 Health Canada Epidemiology summary: https://health-infobase.canada.ca/covid-19/epidemiological-summary-covid-19-cases.html\n\u2022 COVID-19 CANADA Vaccine Production: https://www.cp24.com/news/canada-signs-deal-to-produce-novavax-covid-19-vaccine-at-montreal-plant-1.5291842\n\u2022 COVID-19 Vaccines in Canada: https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19/vaccines.html?gclid=CPHSupaql-8CFYopfwodtzMF9w&gclsrc=ds", "link": "https://www.youtube.com/watch?v=pv43YHlc5xM", "date_published": "2021-03-06 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Evidence based practice, Dr Tess Lawrie", "description": "First part of a fascinating talk with Dr Tess Lawrie. Do come back for the second evidence based part. Thank you so much Dr. Lawrie, both for coming on this channel and for all of the life saving work you are doing.\nFollow the evidence, wherever it leads.", "link": "https://www.youtube.com/watch?v=UY92vb-9vEw", "date_published": "2021-03-06 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Ivermectin Evidence with Dr Tess Lawrie", "description": "Thank you very much Dr. Lawrie. \nIvermectin interview, Dr. Tess Lawrie\n\nIvermectin reduces the risk of death from COVID-19 -a rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance.\n\nhttps://www.researchgate.net/publication/348297284_Ivermectin_reduces_the_risk_of_death_from_COVID-19_-a_rapid_review_and_meta-analysis_in_support_of_the_recommendation_of_the_Front_Line_COVID-19_Critical_Care_Alliance_Latest_version_v12_-_6_Jan_2021\n\nKory P, Meduri GU, Iglesias J, et al. Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. 18 Dec 2020.\nhttps://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-treatment-of-COVID-19.pdf\n\nWorld Health Organization. 21st Model List of Essential Medicines. Geneva, Switzerland. 2019.\nhttps://www.who.int/publications/i/item/WHOMVPEMPIAU2019.06\n\nHiggins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 Cochrane, 2019.\nwww.training.cochrane.org/handbook. \n\nThe GRADE Working Group. GRADE [website] 2020\n www.gradeworkinggroup.org. \n\nAlam MT, Murshed R, Gomes PF, Masud ZM, Saber S, Chaklader MA, Khanam F, Hossain M, Momen ABIM, Yasmin N, Alam RF, Sultana A, Robin RC. Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka \u2013 An Observational Study\nhttps://ejmed.org/index.php/ejmed/article/view/599\n\nElgazzar A, Eltaweel A, Youssef SA, Hany B, Hafez M and Moussa H. Efficacy and Safety of ivermectin for Treatment and prophylaxis of COVID-19 Pandemic. Res. Square [Internet] 28Dec.2020\nhttps://www.researchsquare.com/article/rs-100956/v3\n\nChowdhury, ATMM, Shahbaz, M, Karim, MR, Islam, J, Guo, D, and He, SA Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients.\nhttps://www.researchsquare.com/article/rs-38896/v1\n\nPodder CS, Chowdhury N, Mohim IS and Haque W. (2020). Outcome of ivermectin treated mild to moderate COVID-19 cases: a single-centre, open-label, randomised controlled study. IMC Journal of Medical Science. \n\nNiaee MS, Gheibi N, Namdar P, Allami A, Zolghadr L, Javadi A, et al. Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-centre clinical trial. Res. Square [Internet] 24Nov.2020\nhttps://www.researchsquare.com/article/rs-109670/v1\n\nHashim HA, Maulood MF, Rasheed AM, Fatak DF, Kabah KK, Abdulami AS, et al. Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq. medRxiv [Internet] 2020.10.26.20219345\nhttps://doi.org/10.1101/2020.10.26.20219345\n\nAhmed S, Karim MM, Ross AG, Hossain MS, Clemens JD, Sumiya MK, et al. A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int. J. Infect. Disease [Internet] 2Dec.2020.\nhttps://www.ijidonline.com/article/S1201-9712(20)32506-6/fulltext\n\nChachar AZK, Khan KA, Asif M, Tanveer K, Khaqan A and Basri R. Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients, Int. J. Sciences [Internet] Nov.2020:31-V1.2 6th January 2021 20 35\nhttps://www.ijsciences.com/pub/article/2378\n\nCepelowicz Rajter J, Sherman MS, Fatteh N, Vogel F, Sacks J and Rajter JJ. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019. J. Chest [Internet] 27Oct.2020.\nhttps://journal.chestnet.org/action/showPdf?pii=S0012-3692%2820%2934898-4\n\nKhan SI, Khan SI, Debnath CR, Nath PN, Al Mahtab M, Nabeka H, et al. [Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19.] Archivos de Bronconeumolog\u00eda, 2020. Volume 56, Issue 12, Pages 828-830,ISSN 0300- 2896.Spain.\nhttps://doi.org/10.1016/j.arbres.2020.08.007. \n\nGorial FI, Mashhadani S, Sayaly HM, Dakhil BD, AlMashhadani MM, Aljabory AM, et al. Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (Pilot Trial).MedRxiv. 2020.07.07.20145979;\nhttps://doi.org/10.1101/2020.07.07.20145979\n\nSpoorthi V, Sasank S. Utility of ivermectin and doxycycline combination for the treatment of SARS-CoV-2. International Archives of Integrated Medicine.\nhttps://www.iaimjournal.com/volume-7-issue-10- october-2020/\n\n\u201cI can\u2019t keep doing this.\u201d Doctor pleads for review of data during COVID-19 Senate hearing. 8 December 2020. \nhttps://www.youtube.com/watch?v=Tq8SXOBy-4w", "link": "https://www.youtube.com/watch?v=vYF8bnmdQfY", "date_published": "2021-03-06 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Medical exemptions and Ivermectin", "description": "Friendly Pharmacy 5: https://www.youtube.com/c/FriendlyPharmacy5\nVideos:\n\u2022 Vitamin D & Immunity: https://youtu.be/0dIAyLLhUFg\n\u2022 Oxford/AstraZeneca Vaccine: https://youtu.be/JNR79zDAyj0\n\u2022 COVID-19 VACCINE Q&A PART 1: Ingredients, Speed of Production, mRNA: https://youtu.be/l_LpsPKrxs0\n\n\u2022 Interval between vaccine doses stretched up to 4 months: https://www.cbc.ca/news/politics/naci-interval-advice-change-four-months-1.5934563\n\u2022 Health Canada Epidemiology summary: https://health-infobase.canada.ca/covid-19/epidemiological-summary-covid-19-cases.html\n\u2022 COVID-19 CANADA Vaccine Production: https://www.cp24.com/news/canada-signs-deal-to-produce-novavax-covid-19-vaccine-at-montreal-plant-1.5291842\n\u2022 COVID-19 Vaccines in Canada: https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19/vaccines.html?gclid=CPHSupaql-8CFYopfwodtzMF9w&gclsrc=ds\nIVERMECTIN:\n\u2022 US National Library of Medicine: https://medlineplus.gov/druginfo/meds/a607069.html\n\u2022 Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID\u201019: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404744/\n\nhttps://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30464-8/fulltext", "link": "https://www.youtube.com/watch?v=VS2-QxAM41Y", "date_published": "2021-03-06 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Europe eventually follows AZ evidence", "description": "UK\n\nhttps://covid.joinzoe.com/data\n\nhttps://coronavirus.data.gov.uk\n\nVaccines\n\nFirst dose, 21 million\n\nSecond dose, 1 million\n\nIn the past 7 days\n\nCases, + 46,796\nDown 34%\n\nDeaths, + 1,783 = 124,025\nDown 33%\n\nDeaths, = 140,062\n\nHospitalizations, + 6,557\nDown 29%\n\nONS, Over 80s breaking rules\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronavirusandvaccineattitudesandbehavioursinengland/over80spopulation15februaryto20february2021\n\nUptake\n\nOne dose, 99%\n\nTwo doses,15%\n\n49% perceived coronavirus to be a major or significant risk to them personally without vaccination\n\nTwo out of five (41%) over 80s\n\nwho had received the first dose of a vaccine less than three weeks ago\n\nreported they had met someone other than a household member, care worker or member of their support \nbubble\n\nindoors\n\nOne dose, 25% of over 80s much or somewhat more likely to attend a hospital\n\nTwo doses, 33% of over 80s much or somewhat more likely to attend a hospital\n\nGermany\n\nUK variant\n\nFour weeks ago, 6% of cases\n\nNow, at least 40% of cases\n\nLothar Wieler, Robert Koch Institute\n\nIt is foreseeable that B117 will soon be the predominant variant in Germany\n\nit will be even more difficult to keep the virus in check\n\nbecause B117 is more contagious and even more dangerous in all age groups\n\nDenmark\n\nGiving Oxford/AstraZeneca's vaccine to everyone aged over 18\n\nGermany\n\nAvailable to over 65s\n\nFrance\n\nJens Spahn, Health Minister\n\nThis is good news for any elderly person waiting to be vaccinated. \n\nThey can now be vaccinated faster\n\nGreece, Sweden, Belgium\n\nLikewise\n\nSpain\n\nStill thinking about it\n\nItaly\n\nPostponing elections until after the summer\n\nBlocking a shipment of 250,000 AstraZeneca jabs to Australia\n\nBrussels, export transparency regime, approves blockage\n\nAZ production sites, Italy, Belgium, Netherlands, Germany\n\nItaly has 1.5 million AstraZeneca vaccines and has administered 322,800 \n\nGreg Hunt\n\nAustralia has raised the issue with the European Commission\n\nwe have asked the European Commission to review this decision\n\nSimon Birmingham (Finance Minister)\n\nThe world is in uncharted territory at present, it's unsurprising that some countries would tear up the rule book\n\nCyprus\n\nAllow entry to vaccinated British tourists in May\n\nIsraelis from April\n\nCanada\n\nBC, 4 month interval for Pfizer and Moderna\n\nQuebec, 3 month gap\n\nBrazil\n\nhttps://www.dw.com/en/coronavirus-digest-brazils-bolsonaro-tells-people-stop-whining/a-56778948\n\nPresident, stop whining about COVID-19\n\nCases, + 71,704 + 75,102 = 10,800,000\n\nDeaths, +1,641 + 1,919 + 1,699 = 261,000\n\nUp 25% over past 2 weeks\n\nP.1 variant first detected in Manaus \n\nHonduras\n\nArriving, 4.2 million doses Sputnik V\n\nDelays from the expected COVAX shots, Reuters reported.\n\nGovernment has also ordered 1.4 million from AZ\n\nUnited states\n\nCDC\n\nhttps://covid.cdc.gov/covid-data-tracker/#cases_casesper100klast7days\n\nCases, + 65,424 (7 days, 437,888) = 28,580,198\n\nDeaths, + 1,947 = 571,224\n\nVaccinations\n\nhttps://covid.cdc.gov/covid-data-tracker/#vaccinations\n\nOne dose, 54,035,670 (21.2% 16.3%)\n\nTwo doses, 27,795,980 (10.9% 8.4%)\n\nTexas and Mississippi\n\nhttps://www.washingtonpost.com/nation/2021/03/05/coronavirus-covid-live-updates-us/\n\nDr. Fauci\n\nI don\u2019t know why they\u2019re doing it but it\u2019s certainly, from a public health standpoint, ill-advised\n\ninexplicable\n\nCalifornia\n\nSan Diego Safari Park vaccinated nine gorillas\n\nFour orangutans and five bonobos already had 2 shots\n\nWHO\n\nhttps://www.washingtonpost.com/nation/2021/03/05/coronavirus-covid-live-updates-us/\n\nNo interim report\n\nPublish a full report in coming weeks\n\n\nNew Zealand\n\nLifting lockdown restrictions, Auckland, starting March 7\n\n(15 community cases of B117 in February)", "link": "https://www.youtube.com/watch?v=ffh593GHbLQ", "date_published": "2021-03-05 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]